Brian Baranick - 28 Feb 2025 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
EVP, GM, Precision Oncology
Signature
/s/ Brian Baranick by Mark Busch, attorney-in-fact
Issuer symbol
EXAS
Transactions as of
28 Feb 2025
Net transactions value
-$234,940
Form type
4
Filing time
04 Mar 2025, 16:44:55 UTC
Previous filing
26 Feb 2025
Next filing
07 Aug 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Options Exercise $0 +4,725 +26% $0.000000 22,558 28 Feb 2025 Direct F1
transaction EXAS Common Stock Tax liability $114,768 -2,400 -11% $47.82 20,158 28 Feb 2025 Direct F2
transaction EXAS Common Stock Options Exercise $0 +4,948 +25% $0.000000 25,106 28 Feb 2025 Direct F1
transaction EXAS Common Stock Tax liability $120,172 -2,513 -10% $47.82 22,593 28 Feb 2025 Direct F2, F3
holding EXAS Common Stock 670 28 Feb 2025 Held in 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Restricted Stock Units Options Exercise $0 -4,725 -33% $0.000000 9,450 28 Feb 2025 Common Stock 4,725 Direct F4, F5
transaction EXAS Restricted Stock Units Options Exercise $0 -4,948 -25% $0.000000 14,845 28 Feb 2025 Common Stock 4,948 Direct F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon vesting of a restricted stock unit award.
F2 Represents shares of Common Stock retained by Exact Sciences Corporation for tax withholding purposes in connection with the net-settlement on the issuance of shares of Common Stock in respect to the vesting of certain restricted stock units.
F3 In addition to the shares of Common Stock reported on this Form 4, which total 23,263 shares, Mr. Baranick also holds, in the aggregate, an additional 78,430 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F4 Each restricted stock unit represents a contingent right to receive one share of common stock.
F5 Represents a restricted stock unit award granted on February 24, 2023 that partially vested on February 28, 2025. The restricted stock units vest in four equal annual installments on the last trading day of February.
F6 Represents a restricted stock unit award granted on February 26, 2024 that partially vested on February 28, 2025. The restricted stock units vest in four equal annual installments on the last trading day of February.